SNAP-8
Also known as: Acetyl Octapeptide-3
SNAP-8 is a topical cosmetic peptide derived from SNAP-25, marketed as an alternative to topical Argireline for expression-line reduction.
Pricing for SNAP-8
Live vendor pricing, normalized to $/mg so sizes compare fairly — fused with each seller's Merit trust score and latest independent COA purity. Prices refresh daily.
Average price
$3.71/mg
range $0.00–$10.00/mg
Sellers
49
from $0.00
45-day trend
-8.3%
vs 45-day avg $/mg
41 of 49 sellers have a current price· 26 stale listings hidden (not seen in 7 days)
Top Merit pick
🇺🇸 BioLongevity Labs96✓ verified at source · just now
$0.00/mg -100% vs avg$0.00
10mg
no purity- 🇺🇸 Ion Peptide95
✓ verified at source · just now
$3.90/mg +5.2% vs avg$39.00
10mg
99.7% purity 8 COAs - 🇺🇸 Peptide Tech94
✓ verified at source · 1d ago
$3.50/mg -5.6% vs avg$34.99
10mg
- 🇺🇸 Hydro Research Peptides91
via Disclosed Labs · just now
$2.70/mg -27.2% vs avg$540
200mg
- 🇺🇸 Peptidology89
✓ verified at source · just now
$4.30/mg +16% vs avg$42.99
10mg
- 🇺🇸 Peptide Plugs89
✓ verified at source · just now
$5.00/mg +34.9% vs avg$50.00
10mg
99.7% purity 1 COA - 🇺🇸 Verified Peptides86
via Disclosed Labs · just now
$0.63/mg -83% vs avg$126
200mg
99.8% purity 12 COAs - 🇺🇸 EZ Peptides85
✓ verified at source · just now
$3.50/mg -5.6% vs avg$35.00
10mg
99.4% purity 2 COAs - 🇨🇳 Reta Peptide83
✓ verified at source · just now
$5.00/mg +34.9% vs avg$50.00
10mg
no purity - 🇺🇸 Certified Peptides62
✓ verified at source · just now
$4.10/mg +10.6% vs avg$41.00
10mg
98.7% purity 1 COA - 🇭🇰 Hkuppeptide50
✓ verified at source · just now
$1.00/mg -73% vs avg$10.00
10mg
no purity - 🇭🇰 zztai Peptide Ltd43
✓ verified at source · just now
$5.10/mg +37.6% vs avg$51.00
10mg
no purity - peptidetech.isUnscored
via Disclosed Labs · just now
$3.50/mg -5.6% vs avg$34.99
10mg
no purity - optimasupply.isUnscored
via Disclosed Labs · just now
$3.80/mg +2.5% vs avg$760
200mg
no purity - realpeptides.coUnscored
via Disclosed Labs · just now
$8.00/mg +115.8% vs avg$80.00
10mg
no purity
Prices observed from public storefronts (last 24h), normalized to $/mg. "Evidence" is Merit's 0–100 Merit Score, derived only from observable verification evidence (methodology on /about); "Purity" is the latest independent COA. Some buy links are affiliate links — Merit may earn a commission at no extra cost to you, and where a vendor offers one, the code shown gets you a discount at their checkout. Affiliate status never affects price data, ranking, or the Merit Score (full policy on /disclosure). Research use only.
COAs for SNAP-8
47 third-party tests across 14 vendors. Each card links to the full report.
For
SNAP-8
by Verified Peptides· batch SN806260510E
For
Snap-8
by Ion Peptide· batch SNP10-05042026
For
Snap-8
by Ion Peptide· batch SNP8-04302026
For
Snap-8
by Ion Peptide· batch SNP-04302026
For
Snap-8
by Real Peptides· batch Black Cap
For
SNAP-8
by Amino Club· batch SN0001
For
SNAP-8
by Qihang Peptide· batch 2
For
SNAP-8
by Peptidology· batch 1669
For
SNAP-8
by EZ Peptides· batch EZP-SNAP1012302025-02
For
SNAP-8
by EZ Peptides· batch EZP-SNAP1012302025-02
For
SNAP8
by Ion Peptide· batch SNP8R-123125
For
SNAP8
by Ion Peptide· batch S810-122025
For
SNAP-8
by Ruo Bio· batch SN8001
For
SNAP-8
by Mile High Compounds· batch SNA-010-MH-01
For
SNAP-8
by Mile High Compounds· batch SNA-010-MH-01
For
Snap-8
by Certified Peptides· batch SNP10102325
For
SNAP-8
by Ion Peptide· batch SN1-1025
For
SNAP-8
by Ion Peptide· batch SN1-1025
For
SNAP-8
by Skye Peptides· batch SN25-20-001
For
SNAP-8
by Verified Peptides· batch 07-25-0310C
For
SNAP-8
by Verified Peptides· batch 07-25-0310C
For
SNAP-8
by Profound Aminos· batch 2025-04-03
For
SNAP-8
by Verified Peptides· batch 04-25-0210B
For
SNAP-8
by Verified Peptides· batch 04-25-0210B
12 citations indexed for SNAP-8
case-report · 2026
Hereditary Neuropathy with Liability to Pressure Palsies Mimicking a Chronic Inflammatory Demyelinating Polyneuropathy Variant: A Case Report Highlighting Diagnostic Challenges
We herein report a case of chronic inflammatory demyelinating polyneuropathy (CIDP) that was ultimately identified as hereditary neuropathy with liability to pressure palsies (HNPP) based on PMP22 gene testing.
cohort · 2026
Filtered-phase imaging versus susceptibility-weighted imaging for paramagnetic rim lesion detection in multiple sclerosis: A head-to-head comparison
Background Paramagnetic rim lesions (PRLs) detected on susceptibility-sensitive magnetic resonance imaging (MRI) represent chronic active lesions and correlate with disease progression in multiple sclerosis (MS). However, optimal detection methods remain unclear.
Study · 2026
An Experimental Measurement Method to Characterize and Apply Platinum Silicon Material for a Biomechanical Replica of the Thoracic Aorta
Currently, silicone is a common material used in medical research and biomedical applications. This research aims to characterize extra-soft platinum silicone (shore A 00 50) and compare its mechanical behavior with that of the human thoracic aorta.
Study · 2025
Glycosylated <i>N</i>‑Acyl Phosphoethanolamines as Bacterial Food-Dependent Signaling Molecules in <i>Caenorhabditis</i> Nematodes
N -acyl ethanolamines represent conserved lipophilic signaling molecules that function as endogenous ligands at G-protein-coupled receptors, ion channels, and nuclear receptors.
Study · 2025
Ten Items to Find Them All: Shortening Scales for the Screening of Executive Function in Children With Attention Deficit/Hyperactivity Disorder
Background Attention Deficit/Hyperactivity Disorder (ADHD) is the most common neurodevelopmental disorder. The affectation of executive functions is stressed in the most recent research on ADHD, and many tests are used to assess it in ADHD, but they are usually time- and effort-consuming.
review · 2025
Home Sleep Apnoea Testing: Advances, Challenges and Considerations in Heart Failure
Sleep-disordered breathing (SDB), including obstructive and central sleep apnoea, is highly prevalent in heart failure (HF) and contributes to adverse outcomes. In-lab polysomnography is the diagnostic gold standard, but is limited by cost and accessibility.